India Cancer Therapeutics Market to Grow with a CAGR of 9.80% through 2030
Growth in cancer
screening & early detection is expected to drive the India Cancer
Therapeutics Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “India Cancer Therapeutics Market - By Region and
Competition, Forecast & Opportunities, 2030F”, the India Cancer
Therapeutics Market stood at USD 642.41 Million in 2024 and is anticipated to
grow with a CAGR of 9.80% through 2030. The
increasing focus on cancer screening and early detection is a significant trend
shaping the India Cancer Therapeutics Market. As awareness about cancer rises,
more individuals are undergoing preventive screenings, leading to earlier
diagnosis and improved treatment outcomes. This shift is driven by advancements
in diagnostic technologies, increasing availability of molecular and
imaging-based screening methods, and growing adoption of personalized medicine.
The
emergence of liquid biopsies, AI-powered imaging, and biomarker-driven
screening has revolutionized the way cancer is detected at an early stage.
These technologies enable the identification of cancerous cells even before
symptoms appear, facilitating timely intervention. Moreover, the expansion of
private diagnostic centers and specialized cancer hospitals has improved
accessibility to screening services across urban and semi-urban regions.
Another
key driver of this trend is the increasing involvement of private healthcare
players who are investing in affordable and rapid screening solutions. With
growing patient awareness and improved affordability, there has been a notable
rise in self-initiated screenings, especially for common cancers such as
breast, cervical, lung, and colorectal cancers. Additionally, the integration
of AI and telemedicine is making screening more efficient and accessible,
particularly in rural areas where access to oncologists remains limited.
Furthermore,
the corporate sector is also contributing to this trend by offering cancer
screening programs as part of employee wellness initiatives. Insurance
companies are increasingly covering preventive screenings, making them more
financially viable for the general population. The rising number of cases
detected in early stages is improving survival rates and reducing the burden on
advanced-stage treatment facilities.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India Cancer Therapeutics Market”
The India Cancer
Therapeutics Market is segmented into therapy type, application, regional
distribution, and company.
Based
on Therapy Type, Immunotherapy have emerged as the fastest growing segment in
the India Cancer Therapeutics Market in the forecast period. This is due to its
high efficacy, reduced side effects, and growing adoption of personalized
medicine. Unlike traditional treatments such as chemotherapy, immunotherapy
leverages the body's own immune system to fight cancer, making it a
game-changer in oncology.
The
increasing availability of checkpoint inhibitors, CAR-T cell therapy, and
monoclonal antibodies has driven the segment’s rapid expansion. Additionally,
ongoing clinical trials, regulatory approvals, and collaborations between
Indian biotech firms and global pharmaceutical companies have enhanced
accessibility to these advanced therapies.
Based on Region,
South India have emerged as the fastest growing region in the India Cancer
Therapeutics Market in 2024. This
growth is driven by several factors, including the rapid expansion of
healthcare infrastructure, the presence of top-tier cancer research centers,
and increasing investments in advanced cancer treatments.
The
region is home to leading oncology hospitals and medical research institutions,
such as Tata Medical Center (Chennai), Kidwai Memorial Institute of Oncology
(Bengaluru), and Apollo Cancer Institutes, which are spearheading advancements
in immunotherapy, targeted therapy, and precision medicine. The availability of
world-class cancer care facilities, growing adoption of robotic surgeries, and
advanced radiotherapy solutions has made South India a key hub for cancer
treatment.
Additionally,
higher cancer awareness, increased screening programs, and strong
government-private partnerships have accelerated early diagnosis rates in
cities like Bengaluru, Chennai, Hyderabad, and Kochi. The booming medical
tourism sector in these cities further strengthens the region’s position,
attracting patients from across India and neighboring countries seeking
advanced cancer care.
Major companies
operating in India Cancer Therapeutics Market are:
- Johnson &
Johnson Ltd
- Astellas
Pharma India Pvt. Ltd.
- Eli
Lilly and Company (India) Pvt. Ltd.
- Sanofi
SA
- Ipsen
SA
- Bayer
AG
- AstraZeneca
Pharma India Limited
- Merck
& Co Inc
- Pfizer
Limited
- Sun
Pharmaceutical Industries Ltd.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The growing availability of
cost-effective cancer treatments is transforming oncology care in India. With
the rising burden of cancer cases, the demand for affordable therapeutic
options has intensified, prompting pharmaceutical companies to develop
economical alternatives to expensive biologics. The emergence of biosimilars,
which are highly similar versions of original biologic drugs, has significantly
reduced treatment costs, making advanced therapies accessible to a larger
patient base”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“India
Cancer Therapeutics Market Therapy Type (Chemotherapy, Targeted Therapy,
Immunotherapy, Hormonal Therapy, and Others), By Application (Blood Cancer,
Lung Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer,
Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth
potential of India Cancer Therapeutics Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in India Cancer Therapeutics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com